Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-012252·Erasca, Inc.
Schedule 13G ownership disclosure
Erasca Inc
Common stock, par value $0.0001 per share · CUSIP: 29479A108
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Novartis Pharma AG
Shares: 12,307,692.00 · Class: 4.4%
- Novartis AG
Shares: 12,307,692.00 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-012252
- Form type
- SCHEDULE 13G/A
- Filer
- Erasca, Inc.
- CIK
- CIK 1761918
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership